Walking Group (n = 14) |
Control Group (n = 14) |
(time, interaction) |
||
---|---|---|---|---|
Triacylglycerol (mmol/L) | Baseline | 1.05 (.10) | 1.11 (.12) | .558, 1.000 |
12 weeks | 1.10 (.149 | 1.16 (.19) | ||
TC (mmol/L) | Baseline | 5.84 (.21) | 5.67 (.19) | .979, .189 |
12 weeks | 5.93 (.24) | 5.58 (.17) | ||
HDL-C (mmol/L) | Baseline | 1.79 (.10) | 1.64 (.10) | .001, .049 |
12 weeks | 1.93 (.10) |
1.69 (.10) | ||
LDL-C (mmol/L) | Baseline | 3.40 (.18) | 3.36 (.17) | .215, .603 |
12 weeks | 3.34 (.17) | 3.23 (.17) | ||
Glucose (mmol/L) | Baseline | 5.20 (.24) | 5.10 (.69) | .460, .849 |
12 weeks | 5.15 (.15) | 5.01 (.63) | ||
Insulin (pmol/L) | Baseline | 23.2 (3.1) | 23.7 (3.2) | .155, .687 |
12 weeks | 26.8 (3.3) | 30.2 (8.3) | ||
HbA1c (%) | Baseline | 5.12 (.85) | 5.00 (.03) | .294, .065 |
12 weeks | 5.22 (.12) | 4.97 (.37) | ||
sE-selectin (ng/ml) | Baseline | 37.0 (3.1) | 41.2 (3.2) | .002, .231 |
12 weeks | 34.8 (3.6) | 36.6 (2.8) |
||
sVCAM-1 (ng/ml) | Baseline | 529 (32) | 608 (40) | .001, .878 |
12 weeks | 435 (33) |
518 (37) |
||
C-peptide (pmol/L) | Baseline | 368 (32) | 410 (34) | .629, .357 |
12 weeks | 387 (27) | 404 (36) | ||
Oxidised LDL (U/L) | Baseline | 53.8 (5.5) | 51.2 (5.7) | .075, .743 |
12 weeks | 46.0 (3.7) | 45.8 (4.4) |